Search

Your search keyword '"mdx mouse"' showing total 1,873 results

Search Constraints

Start Over You searched for: Descriptor "mdx mouse" Remove constraint Descriptor: "mdx mouse"
1,873 results on '"mdx mouse"'

Search Results

51. Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.

52. Circulating serum CK level vs. muscle impairment for in situ monitoring burden of disease in Mdx-mice.

53. Molecular hydrogen alleviates motor deficits and muscle degeneration in mdx mice.

54. BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy

55. The microRNA miR‐133b functions to slow Duchenne muscular dystrophy pathogenesis

56. A genotyping method combining primer competition PCR with HRM analysis to identify point mutations in Duchenne animal models

57. Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease

58. Novel Disulfide-Bridged Bioresponsive Antisense Oligonucleotide Induces Efficient Splice Modulation in Muscle Myotubes in Vitro

59. Cognitive impairment appears progressive in the mdx mouse

60. Tetramethylpyrazine Nitrone Improved Motor Deficits and Alleviated Dystrophic Muscle Pathology in the mdx Mouse Model of Duchenne Muscular Dystrophy

61. Syncytial nuclear domains compartmentalize sarcolemmal dystrophin and determine response to therapy in a Duchenne muscular dystrophy mouse model

62. Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse

63. Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology

64. Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice

65. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy

66. Sensitivity to behavioral stress impacts disease pathogenesis in dystrophin‐deficient mice

67. Contraction-Induced Loss of Plasmalemmal Electrophysiological Function Is Dependent on the Dystrophin Glycoprotein Complex

68. Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency

69. Hematopoietic Prostaglandin D Synthase Inhibitor PK007 Decreases Muscle Necrosis in DMD mdx Model Mice

70. Lifespan analysis of dystrophic mdx fast-twitch muscle morphology and its impact on contractile function

71. Overactivity of exercise-sensitive cation channels and their impaired modulation by IGF-1 in mdx native muscle fibers: Beneficial effect of pentoxifylline

72. The high correlation between counts and area fractions of lipofuscin granules, a biomarker of oxidative stress in muscular dystrophies.

73. Degenerative and regenerative features of myofibers differ among skeletal muscles in a murine model of muscular dystrophy.

74. Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy.

75. INCESSANT CYCLES OF DYSTROPHIC MYOFIBER DEGENERATION AND REGENERATION RESULT IN UBIQUITOUS CENTRALLYNUCLEATED FIBERS IN SKELETAL MUSCLES OF X-CHROMOSOME-LINKED MUSCULAR DYSTROPHY (MDX) MOUSE.

76. In vivo treatment with the NF-κB inhibitor ursodeoxycholic acid (UDCA) improves tension development in the isolated mdx costal diaphragm.

77. Age-related T2 changes in hindlimb muscles of mdx mice.

78. Chronic treatment with agents that stabilize cytosolic IκB-α enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch

79. A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle

80. Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy

81. Transcriptomic analysis of mdx mouse muscles reveals a signature of early human Duchenne muscular dystrophy

82. Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients

83. Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy

84. Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model

85. The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo

86. Extrajunctional resting Ca2+ influx is not increased in a severely dystrophic expiratory muscle (triangularis sterni) of the mdx mouse

87. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy

88. Augmenting canonical Wnt signalling in therapeutically inert cells converts them into therapeutically potent exosome factories

89. Eosinophils Do Not Drive Acute Muscle Pathology in the mdx Mouse Model of Duchenne Muscular Dystrophy

90. SPECT Imaging of Muscle Injury with [99mTc]MDP in a Mouse Model of Muscular Dystrophy

91. What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy?

92. Dystrophic mdx mouse myoblasts exhibit elevated ATP/UTP-evoked metabotropic purinergic responses and alterations in calcium signalling

93. Low intensity training improves redox status and reduces collagen fibers on dystrophic muscle

94. Intermittent PTH treatment improves bone and muscle in glucocorticoid treated Mdx mice: A model of Duchenne Muscular Dystrophy

95. α-Methyl-prednisolone normalizes the PKC mediated brain angiogenesis in dystrophic mdx mice

96. Moderate exercise improves function and increases adiponectin in the mdx mouse model of muscular dystrophy

97. rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart

98. Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts

99. Inhibition of microRNA‐92a increases blood vessels and satellite cells in skeletal muscle but does not improve duchenne muscular dystrophy–related phenotype inmdxmice

100. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice

Catalog

Books, media, physical & digital resources